Robert Barrow
2022
In 2022, Robert Barrow earned a total compensation of $5.2M as Chief Executive Officer at Mind Medicine (MindMed), a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $282,500 |
|---|---|
| Option Awards | $2,200,831 |
| Salary | $671,582 |
| Stock Awards | $2,070,402 |
| Other | $2,019 |
| Total | $5,227,334 |
Barrow received $2.2M in option awards, accounting for 42% of the total pay in 2022.
Barrow also received $282.5K in non-equity incentive plan, $671.6K in salary, $2.1M in stock awards and $2K in other compensation.
Rankings
In 2022, Robert Barrow's compensation ranked 603rd out of 5,753 executives tracked by ExecPay. In other words, Barrow earned more than 89.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 603 out of 5,753 | 90th |
Division Manufacturing | 258 out of 3,133 | 92nd |
Major group Chemicals And Allied Products | 81 out of 1,419 | 94th |
Industry group Drugs | 68 out of 1,320 | 95th |
Industry Medicinal Chemicals and Botanical Products | 3 out of 34 | 91st |
Source: SEC filing on April 26, 2024.
Barrow's colleagues
We found two more compensation records of executives who worked with Robert Barrow at Mind Medicine (MindMed) in 2022.